CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoZINZANI, PIER LUIGI
Dettaglio
ZINZANI, PIER LUIGI
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Docenti di ruolo di Ia fascia
P. L. Zinzani; ZINZANI L; [Zinzani PL]; P. ZINZANI; ZINZANI P; ZINZANI P.L.
Pubblicazioni
Risultati 1 - 20 di 404 (tempo di esecuzione: 0.002 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
|---|---|---|---|---|---|---|---|
| 1 | 18 F-FDG PET in malignant lymphoma: significance of positive findings | Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; ...Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S. | 2005 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 1.01 Articolo in rivista | - | |
| 2 | 18[F]FDG small animal PET study of sorafenib efficacy in lymphoma preclinical models. | Ambrosini V; Quarta C; Zinzani PL; Nanni C; Fini M; Torricelli P; Giavaresi G; D'Errico-Grigioni ...A; Malvi D; Franchi R; Fanti S. | 2010 | THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 1.01 Articolo in rivista | - | |
| 3 | 18F-FDG PET early after radiotherapy in lymphoma patients. | CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MAREN...GO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S. | 2004 | CANCER BIOTHERAPY & RADIOPHARMACEUTICALS | 1.01 Articolo in rivista | - | |
| 4 | 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. | Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsa...d M; Franchi R; Fanti S; Zinzani PL. | 2006 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | - | |
| 5 | 18f-FDG small animal PET for early detection of human anaplastic large cell lynphoma xenografts in immunocompromised mice | Ambrosini V.; Quarto C.; Zinzani P.L.; Fini M.; Giavaresi G.; Torricelli P.; Malvi D.; Nanni C.; ...Grassetto G.; Rubellos D.; Fanti S. | 2008 | ANTICANCER RESEARCH | 1.01 Articolo in rivista | - | |
| 6 | [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study. | M. Martelli;L. Ceriani;E. Zucca;P. L. Zinzani;A. J. M;U. Vitolo;C. Stelitano;E. Brusamolino;M. G.... Cabras;L. Rigacci;M. Balzarotti;F. Salvi;S. Montoto;A. Lopez-Guillermo;E. Finolezzi;S. A. Pileri;A. Davies;F. Cavalli;L. Giovanella;P. W. M | 2014 | JOURNAL OF CLINICAL ONCOLOGY | 1.01 Articolo in rivista | - | |
| 7 | 90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years | Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia;... Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi | 2016 | CANCER MEDICINE | 1.01 Articolo in rivista | ||
| 8 | A multicenter phase II trial (SAKK 36/06) of single-agent Everolimus(RAD001) in patients with relapsed or refractory mantle cell lymphoma. | Renner C; Zinzani P.L.; Gressin R; Klingbiel D; Dietrich PY; Hitz F; Bargetzi M; Mingrone W; Mart...inelli G; Trojan A; Bouabdallah K; Lohri A; Gyan E; Biaggi C; Cogliatti S; Bertoni F; Ghielmini M; Brauchli P; Ketterer N. | 2012 | HAEMATOLOGICA | 1.01 Articolo in rivista | - | |
| 9 | A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma | Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenz...ini E.; Baccarani M. | 2008 | CANCER | 1.01 Articolo in rivista | - | |
| 10 | A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. | Zinzani PL; Tani M; Fanti S; Stefoni V; Musuraca G; Castellucci P; Marchi E; Farsad M; Fina M; Pe...llegrini C; Alinari L; Derenzini E; de Vivo A; Bacci F; Pileri S; Baccarani M. | 2008 | ANNALS OF ONCOLOGY | 1.01 Articolo in rivista | - | |
| 11 | A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; P...ellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. | 2012 | ANNALS OF ONCOLOGY | 1.01 Articolo in rivista | - | |
| 12 | ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned. | Viviani S.; Zinzani P.L.; Rambaldi A.; Brusamolino E.; Levis A.; Bonfante V.; Vitolo U.; Pulsoni ...A.; Liberati A.M.; Specchia G.; Valagussa P.; Rossi A.; Zaja F.; Pogliani E.M.; Pregno P.; Gotti M.; Gallamini A.; Rota Scalabrini D.; Bonadonna G.; Gianni A.M.; Michelangelo Foundation; Gruppo Italiano di Terapie Innovative nei Linfomi; Intergruppo Italiano Linfomi | 2011 | NEW ENGLAND JOURNAL OF MEDICINE | 1.01 Articolo in rivista | - | |
| 13 | Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial | Wang, Michael; Rule, Simon; Zinzani, Pier Luigi; Goy, Andre; Casasnovas, Olivier; Smith, Stephen ...D; Damaj, Gandhi; Doorduijn, Jeanette; Lamy, Thierry; Morschhauser, Franck; Panizo, Carlos; Shah, Bijal; Davies, Andrew; Eek, Richard; Dupuis, Jehan; Jacobsen, Eric; Kater, Arnon P; Le Gouill, Steven; Oberic, Lucie; Robak, Taduesz; Covey, Todd; Dua, Richa; Hamdy, Ahmed; Huang, Xin; Izumi, Raquel; Patel, Priti; Rothbaum, Wayne; Slatter, J. Greg; Jurczak, Wojciech | 2018 | THE LANCET | 1.01 Articolo in rivista | - | |
| 14 | Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study | Owen, Roger G; McCarthy, Helen; Rule, Simon; D'Sa, Shirley; Thomas, Sheeba K; Tournilhac, Olivier...; Forconi, Francesco; Kersten, Marie José; Zinzani, Pier Luigi; Iyengar, Sunil; Kothari, Jaimal; Minnema, Monique C; Kastritis, Efstathios; Aurran-Schleinitz, Thérèse; Cheson, Bruce D; Walter, Harriet; Greenwald, Daniel; Chen, Dih-Yih; Frigault, Melanie M; Hamdy, Ahmed; Izumi, Raquel; Patel, Priti; Wei, Helen; Lee, Sun Ku; Mittag, Diana; Furman, Richard R | 2020 | THE LANCET. HAEMATOLOGY | 1.01 Articolo in rivista | - | |
| 15 | Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. | Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J, Hensel M, Hopfinger G, Hess G,... von Grünhagen U, Bergmann M, Catalano J, Zinzani PL, Caligaris-Cappio F, Seymour JF, Berrebi A, Jäger U, Cazin B, Trneny M, Westermann A, Wendtner CM, Eichhorst BF, Staib P, Bühler A, Winkler D, Zenz T, Böttcher S, Ritgen M, Mendila M, Kneba M, Döhner H, Stilgenbauer S; International Group of Investigators; German Chronic Lymphocytic Leukaemia Study Group. | 2010 | THE LANCET | 1.01 Articolo in rivista | - | |
| 16 | Advanced/aggressive CTCL: improving the efficacy of treatment. | Zinzani PL | 2012 | GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA | 1.01 Articolo in rivista | - | |
| 17 | Advances in management of follicular lymphoma. | P. L. Zinzani | 2014 | RINSHO KETSUEKI | 1.01 Articolo in rivista | - | |
| 18 | ALCL: is it now a curable disease? | Zinzani, Pier Luigi | 2017 | BLOOD | 1.01 Articolo in rivista | - | |
| 19 | ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK(+) ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project | Savage, KJ; Harris, NL; Vose, JM; Ullrich, F; Jaffe, ES; Connors, JM; Rimsza, L; Pileri, SA; Chha...nabhai, M; Gascoyne, RD; Armitage, JO; Weisenburger, DD; Zinzani, P | 2008 | BLOOD | 1.01 Articolo in rivista | - | |
| 20 | Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients | Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini ...F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL | 2013 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | - |
Copyright © 2021